Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - TOTAL ASSETS
Total Assets HALO - Halozyme Therapeutics, Inc.
2.06 B
LAST VALUE
5.86%
2 YEAR CAGR
29.53%
5 YEAR CAGR
28.66%
10 YEAR CAGR